InvestorsHub Logo
Followers 31
Posts 6439
Boards Moderated 0
Alias Born 01/20/2016

Re: None

Saturday, 12/24/2016 12:39:26 PM

Saturday, December 24, 2016 12:39:26 PM

Post# of 462365
More on the FDA's recent (yesterday) drug approval.......Billy Dunn, M.D., director of the Division of Neurology Products in the FDA’s Center for Drug Evaluation and Research, touted the agency's flexibility in a prepared statement. He said: “As shown by our suggestion to the sponsor to analyze the results of the study earlier than planned, the FDA is committed to assisting with the development and approval of safe and effective drugs for rare diseases and we worked hard to review this application quickly; we could not be more pleased to have the first approved treatment for this debilitating disease.” Can someone send Dr.Billy Dunn's e-mail address to Dr.Missling??? Kidding--I'm sure Dr.Dunn is familiar with Anavex and 2-73
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News